Experimental heart drug lowering a risk factor made no difference to patient outcomes
Written by AI from npr.org's report. Not checked by a person.
NPR reports a trial of an experimental drug that lowers a common heart-attack risk factor found it did not improve outcomes, contrary to doctors' expectations.
NPR reports that doctors expected an experimental drug that lowers a common risk factor for heart attacks to save lives. In the trial, the medicine made no difference to patients' outcomes. The result is a reminder that improving a biological marker does not always translate into fewer heart attacks or deaths. Further details, including the drug's name and trial size, were not available in the summary reviewed and should be confirmed in the full report.
